Fig. 6From: Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysisForest plots of grade 3–4 adverse events: rates of thrombocytopenia, neutropenia, and infectionBack to article page